Source Legend
- Human-provided
Entered or confirmed by an authorized person.
- Google
Imported Google information.
- Trial-derived
Calculated or extracted directly from associated trial records.
- AI-inferred
A capability inferred from trial history.
- AI-extracted
An explicit statement extracted from an official source.
- Public registry
Information from a public registry.
- Site record
Information held in the site record.
Source: Site record. The Royal Marsden Hospital
Claim This Site
Are you the site administrator? Claim this site to update information.
Basic Information
Site Overview
The Royal Marsden Hospital, located at 203 Fulham Rd., London SW3 6JJ, is the main London site of a world-renowned, specialist National Health Service (NHS) oncology trust. Founded by surgeon William Marsden in 1851, it holds the historic distinction of being the world's first hospital dedicated entirely to cancer diagnosis, treatment, research, and education. Alongside its sister site in Sutton, Surrey, and its academic partner, the Institute of Cancer Research (ICR), the facility constitutes the largest comprehensive cancer centre in Europe. Celebrated for its cutting-edge medical advancements—including hosting Europe's largest drug trials unit—and officially rated "Outstanding" by the UK's Care Quality Commission (CQC), the Chelsea-based hospital delivers highly integrated, world-class diagnostics, therapies, and inpatient care to over 59,000 NHS and private patients every year.
Business Status
Business Category
Business Subcategory
Conditions
Sponsors
Imaging & Diagnostics
Imaging and diagnostic capabilities inferred from trial participation
Laboratory & Biospecimens
Laboratory and biospecimen capabilities inferred from trial participation
Research Pharmacy & Investigational Product
Investigational-product capabilities inferred from trial participation
Clinical Procedures
Clinical procedures inferred from trial participation
Accessibility & Parking
Accessibility Features
Amenities
Amenities Available
Additional Capabilities
Other capabilities inferred from trial participation